Brazil Veterinary Medicine Market Size, Share & Trends Analysis Report By Product (Biologics, Pharmaceuticals, Medicated Feed Additives), By Animal Type, By Route Of Administration, By Distribution, And Segment Forecasts, 2025 - 2030
This report can be delivered to the clients within 3 Business days
Brazil Veterinary Medicine Market Growth & Trends
The Brazil veterinary medicine market size is expected t%li%reach USD 4.15 billion by 2030, registering a CAGR of 7.9% from 2025 t%li%2030, according t%li%a new report by Grand View Research, Inc. The rising pet ownership rate, increased livestock production, and growing demand for advanced veterinary pharmaceuticals and vaccines drive market growth. Expanding government initiatives t%li%improve animal health and the increasing presence of veterinary medicine providers further contribute t%li%market expansion. Advancements in veterinary drug formulations and efforts t%li%enhance disease prevention strategies are als%li%supporting market growth. The growing emphasis on animal welfare and improved access t%li%veterinary healthcare solutions is expected t%li%drive further adoption of veterinary medicines across Brazil.
Brazil is one of the world’s largest exporters of beef and poultry, and this status encourages farmers t%li%adopt rigorous health management practices, including regular veterinary care, vaccination, and disease prevention measures, t%li%ensure high-quality animal protein output. According t%li%the OECD, in 2023, Brazil's beef and veal meat consumption was projected t%li%reach 18.1 kg per person, as compared t%li%17.8 kg per person in 2022. As demand for meat rises, livestock production scales up, requiring improved animal health practices t%li%ensure meat quality and safety standards. Moreover, producers are motivated t%li%invest in animal health t%li%ensure that livestock remains free from diseases and meets the standards for both local consumption and export. This focus on preventive and therapeutic veterinary care further stimulates market growth as producers seek solutions t%li%maintain animal welfare, improve feed efficiency, and reduce mortality rates.
Furthermore, the growth of veterinary healthcare facilities, including new animal clinics and specialized care centers, strengthens the Brazil Veterinary Medicine Market. Better access t%li%veterinary services and improved diagnostic tools are helping detect diseases early and provide effective treatments. In addition, a stronger focus on sustainable livestock management and responsible use of antibiotics is driving the adoption of eco-friendly veterinary solutions. These trends are shaping the market and supporting its continued growth.
Brazil Veterinary Medicine Market Report Highlights
Brazil Veterinary Medicine Market Growth & Trends
The Brazil veterinary medicine market size is expected t%li%reach USD 4.15 billion by 2030, registering a CAGR of 7.9% from 2025 t%li%2030, according t%li%a new report by Grand View Research, Inc. The rising pet ownership rate, increased livestock production, and growing demand for advanced veterinary pharmaceuticals and vaccines drive market growth. Expanding government initiatives t%li%improve animal health and the increasing presence of veterinary medicine providers further contribute t%li%market expansion. Advancements in veterinary drug formulations and efforts t%li%enhance disease prevention strategies are als%li%supporting market growth. The growing emphasis on animal welfare and improved access t%li%veterinary healthcare solutions is expected t%li%drive further adoption of veterinary medicines across Brazil.
Brazil is one of the world’s largest exporters of beef and poultry, and this status encourages farmers t%li%adopt rigorous health management practices, including regular veterinary care, vaccination, and disease prevention measures, t%li%ensure high-quality animal protein output. According t%li%the OECD, in 2023, Brazil's beef and veal meat consumption was projected t%li%reach 18.1 kg per person, as compared t%li%17.8 kg per person in 2022. As demand for meat rises, livestock production scales up, requiring improved animal health practices t%li%ensure meat quality and safety standards. Moreover, producers are motivated t%li%invest in animal health t%li%ensure that livestock remains free from diseases and meets the standards for both local consumption and export. This focus on preventive and therapeutic veterinary care further stimulates market growth as producers seek solutions t%li%maintain animal welfare, improve feed efficiency, and reduce mortality rates.
Furthermore, the growth of veterinary healthcare facilities, including new animal clinics and specialized care centers, strengthens the Brazil Veterinary Medicine Market. Better access t%li%veterinary services and improved diagnostic tools are helping detect diseases early and provide effective treatments. In addition, a stronger focus on sustainable livestock management and responsible use of antibiotics is driving the adoption of eco-friendly veterinary solutions. These trends are shaping the market and supporting its continued growth.
Brazil Veterinary Medicine Market Report Highlights
- By product, pharmaceuticals dominated the market with a share of 67.58% in 2024. However, the biologics segment is expected t%li%grow at the highest CAGR of 8.8% during the forecast period. This growth is driven by increasing demand for vaccines and immunotherapies, along with advancements in biotechnology improving disease prevention and treatment in animals.
- By animal type, production animals held the largest market share in 2024, driven by the growing demand for livestock healthcare and disease management solutions. However, the companion animals segment is expected t%li%grow at the fastest CAGR during the forecast period. This growth is supported by the rising pet population, increasing pet healthcare awareness, and a greater focus on preventive treatments for household animals.
- By route of administration, the injectable segment held the largest market share in 2024 due t%li%its effectiveness in delivering fast-acting treatments for both companion and production animals. However, the other routes segment, including intranasal delivery, controlled-release implants, and transdermal patches, is expected t%li%grow the most during the forecast period. This growth is driven by the increasing adoption of alternative drug delivery methods that enhance convenience, reduce animal stress, and improve treatment adherence.
- By distribution channel, veterinary hospitals and clinics held the largest market share in 2024. The e-commerce segment is expected t%li%grow at the highest CAGR, driven by the convenience and accessibility of online veterinary products.
Table of Content
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation and Scope
1.1.1. Scope
1.1.2. Estimates and Forecast Timeline
1.2. Market Definitions
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. GVR’s Internal Database
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis
1.6.2. Global Market: CAGR Calculation
1.7. Research Scope and Assumptions
1.7.1. List of Secondary Sources
1.7.2. List of Primary Sources
1.7.3. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. BRAZIL VETERINARY MEDICINE MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Drivers Analysis
3.2.1.1. Rising demand for animal protein
3.2.1.2. Supportive initiatives by Government
3.2.2. Market Restraints Analysis
3.2.2.1. Limited access to veterinary care
3.2.3. Market Opportunity Analysis
3.2.4. Market Challenges Analysis
3.3. Brazil Veterinary Medicine Market Analysis Tools
3.3.1. Porter’s Analysis
3.3.1.1. Bargaining power of the suppliers
3.3.1.2. Bargaining power of the buyers
3.3.1.3. Threats of substitution
3.3.1.4. Threats from new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social Landscape
3.3.2.3. Technological landscape
3.3.2.4. Environmental Landscape
3.3.2.5. Legal landscape
3.4. Covid-19 Analysis
3.5. Estimated Pet Population by key countries
CHAPTER 4. BRAZIL VETERINARY MEDICINE MARKET: ANIMAL ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Brazil Veterinary Medicine Market Movement Analysis
4.3. Brazil Veterinary Medicine Market Size & Trend Analysis, by Animal, 2018 to 2030 (USD Million)
4.3.1. Production Animals
4.3.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.1.2. Poultry
4.3.1.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.1.3. Swine
4.3.1.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.1.4. Cattles
4.3.1.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.1.5. Sheep & Goats
4.3.1.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.1.6. Fish
4.3.1.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2. Companion Animals
4.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2.2. Dogs
4.3.2.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2.3. Cats
4.3.2.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2.4. Horses
4.3.2.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2.5. Others
4.3.2.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 5. BRAZIL VETERINARY MEDICINE MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Brazil Veterinary Medicine Market Movement Analysis
5.3. Brazil Veterinary Medicine Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
5.3.1. Biologics
5.3.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.1.2. Vaccines
5.3.1.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.1.2.2. Attenuated Live Vaccines
5.3.1.2.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.1.2.3. Inactivated Vaccines
5.3.1.2.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.1.2.4. Subunit Vaccines
5.3.1.2.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.1.2.5. DNA Vaccines
5.3.1.2.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.1.2.5.2. Recombinant Vaccines
5.3.1.2.5.3. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.1.2.5.4. Autogenous Vaccines
5.3.1.2.5.5. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.1.2.5.6. Other Biologics
5.3.1.2.5.7. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.2. Pharmaceuticals
5.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.2.2. Parasiticides
5.3.2.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.2.3. Anti-infectives
5.3.2.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.2.4. Anti-inflammatory
5.3.2.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.2.5. Analgesics
5.3.2.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.2.6. Other Pharmaceuticals
5.3.2.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.3. Medicinal Feed Additives
5.3.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
CHAPTER 6. BRAZIL VETERINARY MEDICINE MARKET: TYPE OF VACCINE ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Brazil Veterinary Medicine Market Movement Analysis
6.3. Brazil Veterinary Medicine Market Size & Trend Analysis, by Type of Vaccine, 2018 to 2030 (USD Million)
6.3.1. Cattle Vaccine
6.3.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
6.3.2. Porcine Vaccine
6.3.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
6.3.3. Poultry Vaccine
6.3.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
6.3.4. Aquaculture Vaccine
6.3.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
6.3.5. Other Vaccines
6.3.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
CHAPTER 7. BRAZIL VETERINARY MEDICINE MARKET: DISEASE ESTIMATES & TREND ANALYSIS
7.1. Segment Dashboard
7.2. Brazil Veterinary Medicine Market Movement Analysis
7.3. Brazil Veterinary Medicine Market Size & Trend Analysis, by Disease, 2018 to 2030 (USD Million)
7.3.1. Cattle Disease
7.3.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
7.3.2. Porcine Disease
7.3.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
7.3.3. Poultry Disease
7.3.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
7.3.4. Aquaculture Disease
7.3.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
7.3.5. Other Disease
7.3.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
CHAPTER 8. BRAZIL VETERINARY MEDICINE MARKET: ROUTE OF ADMINISTRATION ESTIMATES & TREND ANALYSIS
8.1. Segment Dashboard
8.2. Brazil Veterinary Medicine Market Movement Analysis
8.3. Brazil Veterinary Medicine Market Size & Trend Analysis, by Route of Administration, 2018 to 2030 (USD Million)
8.3.1. Oral
8.3.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
8.3.2. Injectable
8.3.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
8.3.2.2. Subcutaneous
8.3.2.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
8.3.2.3. Intramuscular
8.3.2.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
8.3.2.4. Intravenous
8.3.2.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
8.3.3. Topical
8.3.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
8.3.4. Other
8.3.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
CHAPTER 9. BRAZIL VETERINARY MEDICINE MARKET: DISTRIBUTION CHANNEL ESTIMATES & TREND ANALYSIS
9.1. Segment Dashboard
9.2. Brazil Veterinary Medicine Market Movement Analysis
9.3. Brazil Veterinary Medicine Market Size & Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
9.3.1. Retail
9.3.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
9.3.2. E-Commerce
9.3.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
9.3.3. Hospital/ Clinic Pharmacy
9.3.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
CHAPTER 10. COMPETITIVE LANDSCAPE
10.1. Market Participant Categorization
10.2. Company Market Position Analysis/ Heat Map Analysis
10.3. Strategy Mapping
10.3.1. Mergers & Acquisitions
10.3.2. Partnerships & Collaborations
10.3.3. Others
10.4. Company Profiles
10.4.1. Zoetis Inc.
10.4.1.1. Participant’s Overview
10.4.1.2. Financial Performance
10.4.1.3. Product Benchmarking
10.4.1.4. Strategic Initiatives
10.4.2. Ceva Santй Animale
10.4.2.1. Participant’s Overview
10.4.2.2. Financial Performance
10.4.2.3. Product Benchmarking
10.4.2.4. Strategic Initiatives
10.4.3. Merck & Co., Inc.
10.4.3.1. Participant’s Overview
10.4.3.2. Financial Performance
10.4.3.3. Product Benchmarking
10.4.3.4. Strategic Initiatives
10.4.4. Vetoquinol S.A.
10.4.4.1. Participant’s Overview
10.4.4.2. Financial Performance
10.4.4.3. Product Benchmarking
10.4.4.4. Strategic Initiatives
10.4.5. Boehringer Ingelheim Gmbh
10.4.5.1. Participant’s Overview
10.4.5.2. Financial Performance
10.4.5.3. Product Benchmarking
10.4.5.4. Strategic Initiatives
10.4.6. Elanco Animal Health Incorporated
10.4.6.1. Participant’s Overview
10.4.6.2. Financial Performance
10.4.6.3. Product Benchmarking
10.4.6.4. Strategic Initiatives
10.4.7. Biogйnesis Bagу
10.4.7.1. Participant’s Overview
10.4.7.2. Financial Performance
10.4.7.3. Product Benchmarking
10.4.7.4. Strategic Initiatives
10.4.8. Phibro Animal Health Corporation
10.4.8.1. Participant’s Overview
10.4.8.2. Financial Performance
10.4.8.3. Product Benchmarking
10.4.8.4. Strategic Initiatives
10.4.9. Dechra Pharmaceuticals Plc
10.4.9.1. Participant’s Overview
10.4.9.2. Financial Performance
10.4.9.3. Product Benchmarking
10.4.9.4. Strategic Initiatives
10.4.10. Bimeda, Inc.
10.4.10.1. Participant’s Overview
10.4.10.2. Financial Performance
10.4.10.3. Product Benchmarking
10.4.10.4. Strategic Initiatives
10.4.11. Biogйnesis Bagу.
10.4.11.1. Participant’s Overview
10.4.11.2. Financial Performance
10.4.11.3. Product Benchmarking
10.4.11.4. Strategic Initiatives
10.4.12. Ourofino Saъde Animal.
10.4.12.1. Participant’s Overview
10.4.12.2. Financial Performance
10.4.12.3. Product Benchmarking
10.4.12.4. Strategic Initiatives
10.4.13. FARMABASE
10.4.13.1. Participant’s Overview
10.4.13.2. Financial Performance
10.4.13.3. Product Benchmarking
10.4.13.4. Strategic Initiatives
10.4.14. Vetnil
10.4.14.1. Participant’s Overview
10.4.14.2. Financial Performance
10.4.14.3. Product Benchmarking
10.4.14.4. Strategic Initiatives
10.4.15. Alivira Saъde Animal
10.4.15.1. Participant’s Overview
10.4.15.2. Financial Performance
10.4.15.3. Product Benchmarking
10.4.15.4. Strategic Initiatives
CHAPTER 11. KEY TAKEAWAYS
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation and Scope
1.1.1. Scope
1.1.2. Estimates and Forecast Timeline
1.2. Market Definitions
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. GVR’s Internal Database
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis
1.6.2. Global Market: CAGR Calculation
1.7. Research Scope and Assumptions
1.7.1. List of Secondary Sources
1.7.2. List of Primary Sources
1.7.3. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. BRAZIL VETERINARY MEDICINE MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Drivers Analysis
3.2.1.1. Rising demand for animal protein
3.2.1.2. Supportive initiatives by Government
3.2.2. Market Restraints Analysis
3.2.2.1. Limited access to veterinary care
3.2.3. Market Opportunity Analysis
3.2.4. Market Challenges Analysis
3.3. Brazil Veterinary Medicine Market Analysis Tools
3.3.1. Porter’s Analysis
3.3.1.1. Bargaining power of the suppliers
3.3.1.2. Bargaining power of the buyers
3.3.1.3. Threats of substitution
3.3.1.4. Threats from new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social Landscape
3.3.2.3. Technological landscape
3.3.2.4. Environmental Landscape
3.3.2.5. Legal landscape
3.4. Covid-19 Analysis
3.5. Estimated Pet Population by key countries
CHAPTER 4. BRAZIL VETERINARY MEDICINE MARKET: ANIMAL ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Brazil Veterinary Medicine Market Movement Analysis
4.3. Brazil Veterinary Medicine Market Size & Trend Analysis, by Animal, 2018 to 2030 (USD Million)
4.3.1. Production Animals
4.3.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.1.2. Poultry
4.3.1.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.1.3. Swine
4.3.1.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.1.4. Cattles
4.3.1.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.1.5. Sheep & Goats
4.3.1.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.1.6. Fish
4.3.1.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2. Companion Animals
4.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2.2. Dogs
4.3.2.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2.3. Cats
4.3.2.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2.4. Horses
4.3.2.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2.5. Others
4.3.2.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 5. BRAZIL VETERINARY MEDICINE MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Brazil Veterinary Medicine Market Movement Analysis
5.3. Brazil Veterinary Medicine Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
5.3.1. Biologics
5.3.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.1.2. Vaccines
5.3.1.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.1.2.2. Attenuated Live Vaccines
5.3.1.2.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.1.2.3. Inactivated Vaccines
5.3.1.2.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.1.2.4. Subunit Vaccines
5.3.1.2.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.1.2.5. DNA Vaccines
5.3.1.2.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.1.2.5.2. Recombinant Vaccines
5.3.1.2.5.3. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.1.2.5.4. Autogenous Vaccines
5.3.1.2.5.5. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.1.2.5.6. Other Biologics
5.3.1.2.5.7. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.2. Pharmaceuticals
5.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.2.2. Parasiticides
5.3.2.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.2.3. Anti-infectives
5.3.2.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.2.4. Anti-inflammatory
5.3.2.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.2.5. Analgesics
5.3.2.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.2.6. Other Pharmaceuticals
5.3.2.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.3. Medicinal Feed Additives
5.3.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
CHAPTER 6. BRAZIL VETERINARY MEDICINE MARKET: TYPE OF VACCINE ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Brazil Veterinary Medicine Market Movement Analysis
6.3. Brazil Veterinary Medicine Market Size & Trend Analysis, by Type of Vaccine, 2018 to 2030 (USD Million)
6.3.1. Cattle Vaccine
6.3.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
6.3.2. Porcine Vaccine
6.3.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
6.3.3. Poultry Vaccine
6.3.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
6.3.4. Aquaculture Vaccine
6.3.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
6.3.5. Other Vaccines
6.3.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
CHAPTER 7. BRAZIL VETERINARY MEDICINE MARKET: DISEASE ESTIMATES & TREND ANALYSIS
7.1. Segment Dashboard
7.2. Brazil Veterinary Medicine Market Movement Analysis
7.3. Brazil Veterinary Medicine Market Size & Trend Analysis, by Disease, 2018 to 2030 (USD Million)
7.3.1. Cattle Disease
7.3.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
7.3.2. Porcine Disease
7.3.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
7.3.3. Poultry Disease
7.3.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
7.3.4. Aquaculture Disease
7.3.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
7.3.5. Other Disease
7.3.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
CHAPTER 8. BRAZIL VETERINARY MEDICINE MARKET: ROUTE OF ADMINISTRATION ESTIMATES & TREND ANALYSIS
8.1. Segment Dashboard
8.2. Brazil Veterinary Medicine Market Movement Analysis
8.3. Brazil Veterinary Medicine Market Size & Trend Analysis, by Route of Administration, 2018 to 2030 (USD Million)
8.3.1. Oral
8.3.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
8.3.2. Injectable
8.3.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
8.3.2.2. Subcutaneous
8.3.2.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
8.3.2.3. Intramuscular
8.3.2.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
8.3.2.4. Intravenous
8.3.2.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
8.3.3. Topical
8.3.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
8.3.4. Other
8.3.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
CHAPTER 9. BRAZIL VETERINARY MEDICINE MARKET: DISTRIBUTION CHANNEL ESTIMATES & TREND ANALYSIS
9.1. Segment Dashboard
9.2. Brazil Veterinary Medicine Market Movement Analysis
9.3. Brazil Veterinary Medicine Market Size & Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
9.3.1. Retail
9.3.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
9.3.2. E-Commerce
9.3.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
9.3.3. Hospital/ Clinic Pharmacy
9.3.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
CHAPTER 10. COMPETITIVE LANDSCAPE
10.1. Market Participant Categorization
10.2. Company Market Position Analysis/ Heat Map Analysis
10.3. Strategy Mapping
10.3.1. Mergers & Acquisitions
10.3.2. Partnerships & Collaborations
10.3.3. Others
10.4. Company Profiles
10.4.1. Zoetis Inc.
10.4.1.1. Participant’s Overview
10.4.1.2. Financial Performance
10.4.1.3. Product Benchmarking
10.4.1.4. Strategic Initiatives
10.4.2. Ceva Santй Animale
10.4.2.1. Participant’s Overview
10.4.2.2. Financial Performance
10.4.2.3. Product Benchmarking
10.4.2.4. Strategic Initiatives
10.4.3. Merck & Co., Inc.
10.4.3.1. Participant’s Overview
10.4.3.2. Financial Performance
10.4.3.3. Product Benchmarking
10.4.3.4. Strategic Initiatives
10.4.4. Vetoquinol S.A.
10.4.4.1. Participant’s Overview
10.4.4.2. Financial Performance
10.4.4.3. Product Benchmarking
10.4.4.4. Strategic Initiatives
10.4.5. Boehringer Ingelheim Gmbh
10.4.5.1. Participant’s Overview
10.4.5.2. Financial Performance
10.4.5.3. Product Benchmarking
10.4.5.4. Strategic Initiatives
10.4.6. Elanco Animal Health Incorporated
10.4.6.1. Participant’s Overview
10.4.6.2. Financial Performance
10.4.6.3. Product Benchmarking
10.4.6.4. Strategic Initiatives
10.4.7. Biogйnesis Bagу
10.4.7.1. Participant’s Overview
10.4.7.2. Financial Performance
10.4.7.3. Product Benchmarking
10.4.7.4. Strategic Initiatives
10.4.8. Phibro Animal Health Corporation
10.4.8.1. Participant’s Overview
10.4.8.2. Financial Performance
10.4.8.3. Product Benchmarking
10.4.8.4. Strategic Initiatives
10.4.9. Dechra Pharmaceuticals Plc
10.4.9.1. Participant’s Overview
10.4.9.2. Financial Performance
10.4.9.3. Product Benchmarking
10.4.9.4. Strategic Initiatives
10.4.10. Bimeda, Inc.
10.4.10.1. Participant’s Overview
10.4.10.2. Financial Performance
10.4.10.3. Product Benchmarking
10.4.10.4. Strategic Initiatives
10.4.11. Biogйnesis Bagу.
10.4.11.1. Participant’s Overview
10.4.11.2. Financial Performance
10.4.11.3. Product Benchmarking
10.4.11.4. Strategic Initiatives
10.4.12. Ourofino Saъde Animal.
10.4.12.1. Participant’s Overview
10.4.12.2. Financial Performance
10.4.12.3. Product Benchmarking
10.4.12.4. Strategic Initiatives
10.4.13. FARMABASE
10.4.13.1. Participant’s Overview
10.4.13.2. Financial Performance
10.4.13.3. Product Benchmarking
10.4.13.4. Strategic Initiatives
10.4.14. Vetnil
10.4.14.1. Participant’s Overview
10.4.14.2. Financial Performance
10.4.14.3. Product Benchmarking
10.4.14.4. Strategic Initiatives
10.4.15. Alivira Saъde Animal
10.4.15.1. Participant’s Overview
10.4.15.2. Financial Performance
10.4.15.3. Product Benchmarking
10.4.15.4. Strategic Initiatives
CHAPTER 11. KEY TAKEAWAYS
